Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
Logo Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
 

ensayos controlados aleatorios como tema Tag

18 Abr [149] ¿Qué utilidad tiene el Paxlovid® en 2024?

Posted at 18:18h in Therapeutics Letter-ES 0 Comments
Share

Saltar al: Resumen | Texto Completo | Resumen en Términos Sencillos | Infografía | Conclusiones | Bibliografía [caption id="attachment_10551" align="alignright" width="225"] Haga clic en la imagen para abrir la versión de alta resolución de la infografía.[/caption] Resumen...

Read More

adultos mayores agentes antibacterianos agentes broncodilatadores agonistas beta adrenérgicos agonistas β2 de larga duración analgésicos anticolinérgicos antidepresivos análisis de costo-beneficio costos de medicamentos covid-19 dejar de fumar deprescribiendo descontinuación de medicamentos desprescripción detección masiva dolor dolor crónico dolor neuropático E. coli educación del paciente efectos adversos Efectos secundarios y reacciones adversas relacionados con los medicamentos efectos secundarios y reacciones adversas relacionados con medicamentos enfermedad pulmonar obstructiva crónica ensayos controlados aleatorios como tema evaluación de riesgos factores de riesgo gabapentina hidrocodona IBP inhaladores de dosis medida Inhibidores de la Bomba de Protones Nirmatrelvir opioides osteoporosis Paxlovid prediabetes pregabalina revisión sistemática Ritonavir seguridad seguridad del paciente sobrediagnóstico tramadol

Therapeutics Initiative logo

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. More about us

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine.

Donate

 

Contact

Therapeutics Initiative
Dept of Anesthesiology, Pharmacology & Therapeutics
Faculty of Medicine
University of British Columbia

300 - 2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

210 - 1110 Government Street
Victoria, BC, Canada V8W 1Y2

Office: +1 604-822-0700
Send us a message

 

Subscribe for Updates

Want to stay abreast of new therapeutics information? Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. We promise not to spam you and you won’t hear from us more than a few times a month.

Subscribe

Located on the traditional, ancestral and unceded territory of the hən̓q̓əmin̓əm̓ speaking peoples, including the xʷməθkwəy̓əm (Musqueam), the Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and the Skwxwú7mesh (Squamish) Nations, and on the lək̓ʷəŋən (Lekwungen) territory of the Songhees, Esquimalt and W̱SÁNEĆ peoples.

 
© Copyright 1994 - 2022 Therapeutics Initiative | Terms & Policies